Considering the similar pathologic mechanisms between atherosclerosis and CAVD, we conjectured that NCAM1 might also be a new biomarker for aortic valve stenosis. This evidence concerns the gene NCAM1 and congenital bilateral aplasia of vas deferens from CFTR mutation.